Rybicki Frank J, Otero Hansel J, Steigner Michael L, Vorobiof Gabriel, Nallamshetty Leelakrishna, Mitsouras Dimitrios, Ersoy Hale, Mather Richard T, Judy Philip F, Cai Tianxi, Coyner Karl, Schultz Kurt, Whitmore Amanda G, Di Carli Marcelo F
Noninvasive Cardiovascular Imaging, Brigham and Women's Hospital, Boston, MA 02115, USA.
Int J Cardiovasc Imaging. 2008 Jun;24(5):535-46. doi: 10.1007/s10554-008-9308-2. Epub 2008 Mar 27.
To evaluate image quality and contrast opacification from coronary images acquired from 320-detector row computed tomography (CT). Patient dose is estimated for prospective and retrospective ECG-gating; initial correlation between 320-slice CT and coronary catheterization is illustrated.
Retrospective image evaluation from forty consecutive patients included subjective assessment of image quality and contrast opacification (80 ml iopamidol 370 mg I/ml followed by 40 ml saline). Region of interest opacification measurements at the ostium and at 2.5 mm diameter were used to determine the gradient of contrast opacification (defined as the proximal minus distal HU measurements) in coronary arteries imaged in a single heartbeat. Estimated effective dose was compared for prospective versus retrospective ECG-gating, two body mass index categories (30 kg/m(2) cutoff), and single versus two heartbeat acquisition. When available, CT findings were correlated with those from coronary catheterization.
Over 89% of arterial segments (15 segment model) had excellent image quality. The most common reason for image degradation was cardiac motion. One segment in one patient was considered unevaluable. Contrast opacification was almost universally considered excellent. The mean Hounsfield units (HU) was greater than 350; the coronary contrast opacification gradient was 30-50 HU. Patient doses were greater for retrospective ECG-gating, larger patients, and those imaged with two heartbeats. For the most common (n=25) protocol (120 kV, 400 mA, prospective ECG-gating, 60-100% phase window, 16 cm craniocaudal coverage, single heartbeat), the mean dose was 6.8+/-1.4 mSv. All CT findings were confirmed in the four patients who underwent coronary catheterization.
Initial 320-detector row coronary CT images have consistently excellent quality and iodinated contrast opacification. These patients were scanned with conservative protocols with respect to iodine load, prospective ECG-gating phase window, and craniocaudal coverage. Future work will focus on lowering contrast and radiation dose while maintaining image quality.
评估320排计算机断层扫描(CT)获取的冠状动脉图像的图像质量和对比剂充盈情况。估计前瞻性和回顾性心电图门控的患者剂量;阐述320层CT与冠状动脉造影之间的初步相关性。
对40例连续患者进行回顾性图像评估,包括图像质量和对比剂充盈情况的主观评估(80 ml碘帕醇370 mg I/ml,随后注入40 ml生理盐水)。在单个心动周期成像的冠状动脉中,使用窦口和直径2.5 mm处的感兴趣区充盈测量来确定对比剂充盈梯度(定义为近端减去远端的HU测量值)。比较前瞻性与回顾性心电图门控、两种体重指数类别(以30 kg/m²为界)以及单心动周期与双心动周期采集的估计有效剂量。若可行,将CT结果与冠状动脉造影结果进行相关性分析。
超过89%的动脉节段(15节段模型)图像质量极佳。图像质量下降的最常见原因是心脏运动。1例患者的1个节段被认为无法评估。对比剂充盈情况几乎普遍被认为极佳。平均亨氏单位(HU)大于350;冠状动脉对比剂充盈梯度为30 - 50 HU。回顾性心电图门控、体型较大的患者以及双心动周期成像的患者剂量更高。对于最常用的(n = 25)方案(120 kV,400 mA,前瞻性心电图门控,60 - 100%相位窗,16 cm颅尾覆盖,单心动周期),平均剂量为6.8±1.4 mSv。接受冠状动脉造影的4例患者的所有CT结果均得到证实。
最初的320排冠状动脉CT图像质量始终极佳,碘对比剂充盈良好。这些患者在碘负荷、前瞻性心电图门控相位窗和颅尾覆盖方面采用了保守方案进行扫描。未来的工作将集中在降低对比剂和辐射剂量的同时保持图像质量。